Paul Carlier, a professor in the Department of Chemistry in the Virginia Tech College of Science and director of the Virginia Tech Center for Drug Discovery, and his colleagues received a $3.7 million grant from the National Institutes of Health to begin further testing of two inexpensive and effective antimalarial drug candidates that can kill Plasmodium parasites at three different stages of their development.